GSK faces corruption allegations in Syria
27/07/2014 6:20 am EDT

share with your network:

British pharmaceutical company, GlaxoSmithKline and its distributor in Syria have been accused of paying bribes to secure business, Reuters has reported, citing a whistleblower’s email. The allegations relate to its former consumer healthcare operations in Syria, which were closed down in 2012 due to the worsening civil war in the country. GSK said it was investigating the latest claims dating back to 2010, which were laid out in the email received by the company on July 18. “We have zero tolerance for any kind of unethical behaviour. We will thoroughly investigate all the claims made in this email,” GSK said.

About the Author

share with your network:

Share your view

© 1996-2015 Media quest FZ LLC A media and entertainment company
Middle East Main Office
[email protected]
© 2015 Dubai Business | Ameinfo . All rights Reserved.